Antibodies Publications

by Ed Davis | May 23, 2017 | Publications by Technology Area

View selected publications citing GeneCopoeia’s Antibody products from the recent literature

2025

Chen, Y., et al. (2025). Ddx3xa mutations drive cardiac defects in a zebrafish model via dysregulation of wnt/β-catenin signaling. Frontiers in Molecular Biosciences DOI: 10.3389/fmolb.2025.1689202 [anti-DDX3X antibody]

2023

Montalvo, A.P., et al. (2023). An adult clock component links circadian rhythms to pancreatic β-cell maturation. bioRxiv. doi: 10.1101/2023.08.11.552890 [DEC2-V5 (Homo sapiens basic helix-loop-helix family member e41 (BHLHE41)) antibodies]

2022

Wang, B.D., et al. (2022). miR-31 from Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviates Intervertebral Disc Degeneration by Inhibiting NFAT5 and Upregulating the Wnt/β-Catenin Pathway. Stem Cells Int doi: 10.1155/2022/2164057 [anti-NC; GL–02]
Smulders, L., et al. (2022). Phosphatidylinositol Monophosphates Regulate the Membrane Localization of HSPA1A, a Stress-Inducible 70-kDa Heat Shock Protein. Biomolecules doi: 10.3390/biom12060856 [OmicsLink™ monoclonal mouse anti-GFP antibody; OmicsLink™ anti-c-Myc antibody]

2019

Mizui, T., et al. (2019). Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia. Journal of Psychiatric Research doi: 10.1016/j.jpsychires.2019.03.024 [OmicsLink™ anti-human proBDNF antibody]
Benicky, J., et a.. (2019).N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures. The Journal of Biological Chemistry doi: 10.1074/jbc.RA119.009989 [OmicsLink™ anti-human proBDNF antibody]

2017

Yang, B., et al. (2017). Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis. Translational Psychiatry doi: 10.1038/tp.2017.95 [OmicsLink™ anti-human proBDNF antibody]
Zhang, S., et al. (2017). Inhibition of BDNF production by MPP+ through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model. Neuorscience Letters doi: 10.1016/j.neulet.2017.10.014 [OmicsLink™ anti-human proBDNF antibody]
Nguyen, H., et al. (2017). Higher Order Oligomerization of the Licensing ORC4 Protein Is Required for Polar Body Extrusion in Murine Meiosis. Journal of Cellular Biochemistry doi: 10.1002/jcb.25949 [OmicsLink™ monoclonal mouse anti-His antibody]

LysoBeacon™ Blue, 1 mg/ml LysoBeacon™ Green, 1 mg/ml

Price:	$100.00 $100.00
Catalog#:	C047 C048
XX:	1 ml 1 ml
Size:	1 ml 1 ml
Qty:
Manual:

View your cart

Introduction

Lysosomes are membrane-bound cell organelles found in most animal cells. Lysosomes maintain acidic environment of about pH 4.5, and contain acid hydrolase enzymes that break down waste materials and cellular debris. GeneCopoeia offers LysoBeacon™ probes that appear to accumulate in acidic organelles. Our LysoBeacon™ probes exhibit a pH-dependent increase in fluorescence intensity upon acidification.

Lysosome Stains Selection Guide

Cat #	Product Name	Ex/Em (nm)	Applications
C047	LysoBeacon™ Blue	370/425	Lysosome labeling
C048	LysoBeacon™ Green	443/505	Lysosome labeling

Stable Cell Lines Publications

by Ed Davis | May 2, 2017 | Publications by Technology Area

View selected publications citing GeneCopoeia’s Stable Cell Lines from the recent literature

2026

Vasconcellos, J.F., et al. (2026). A genome-wide CRISPR/Cas9 screen reveals novel positive regulators of FTY720 sensitivity in acute lymphoblastic leukemia cells. BMC Research Notes DOI: 10.1186/s13104-026-07654-4 [GeneHero™ Jurkat cell line stably expressing CRISPR Cas9 nuclease, Cat. No. SL555]

2025

Lalchungnunga, H., et al. (2025). Deconvolution of haematological cancer methylation patterns reveals a predominantly non-disease related proliferation signal and uncovers true disease associated methylation changes. British Journal of Cancer DOI: 10.1038/s41416-025-03239-3 [Gateway Entry Clone for Human THEM4, Cat. No. GC-I1844; EndoFectin™ Lenti Transfection Reagent]
Xue, Z., et al. (2025). The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts. Neuro-Oncology DOI: 10.1093/neuonc/noaf102 [Short tandem repeat (STR) profiling]
Pivniouk, V., et al. (2025). IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting ACE2-mediated virus binding and cell entry. ImmunoHorizons DOI: 10.1093/immhor/vlaf056 [HEK293T cells stably expressing human ACE2]
Ireland, J., et al. (2025). Vaccination protects against COVID-associated pulmonary fibrin deposition. Journal of Virology DOI: 10.1128/jvi.00633-25 [HEK293T cells stably expressing human ACE2]
Sergeeva, O.A., et al. (2025). EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. Proceedings of the National Academy of Sciences of the United States of America DOI: 10.1073/pnas.2510829122 [Luciferase/GFP dual‐labeled MDA-MB-468, HCT116, MDA-MB-231 cancer cell lines]
Byrnes, C., et al. (2025). 1-Deoxysphingolipids Require Very-Long-Chain Ceramide Synthesis to Induce ER Stress and Neurotoxicity. bioRxiv DOI: 10.64898/2025.12.06.692689 [GeneHero™ SH-SY5Y Cas9-expressing stable cell line, Cat. No. SL550]
García-Rodríguez, F.M., et al. (2025). Structurally related phage helicases trigger type III-A3 retron-mediated anti-phage defense across diverse tailed phage families. Nucleic Acids Research DOI: 10.1093/nar/gkaf1396 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502]
Tu, C-M., et al. (2025). Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression. Scientific Reports DOI: 10.1038/s41598-025-29622-x [CT26 mouse colon carcinoma cancer cell line dual-labeled with luciferase and GFP, Cat. No. SL021]
Janon, A., et al. (2025). Free-floating long-term vascularized mesenchymal organoids. iScience DOI: 10.1016/j.isci.2025.114548 [Luciferase/GFP Dual‐labeled MCF7 Cancer Cell Line, Cat. No. SL117]
Wang, B., et al. (2025). Structural basis for retron co-option of anti-phage ATPase-nuclease. Nature Structural & Molecular Biology DOI: 10.1038/s41594-025-01702-6 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502]
Garellick, V.A., et al. (2025). Amino acid restriction sensitizes lung cancer cells to ferroptosis via GCN2-dependent activation of the integrated stress response. Redox Biology DOI: 10.1016/j.redox.2025.103988 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL504]
Zheng, Q., et al. (2025). Distal Covalent Targeting Suppresses Signaling of Oncogenic K‑Ras(G13C) in Cancer Cells. ACS Chem Biol DOI: 10.1021/acschembio.5c00249 [OncoSpot™ KRAS G13C Homozygous HCT116 Cancer Biomarker Mutant Cell Line]
Arevalo, J.A., et al. (2025). Age-related declines in mitochondrial Prdx6 contribute to dysregulated muscle bioenergetics. Redox Biol DOI: 10.1016/j.redox.2025.103808 [GeneHero™ C2C12-Cas9-hyg Stable Cell Line, Cat. No. SL564]
Martín-Escolano, J., et al. (2025). Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis. PLoS One DOI: 10.1371/journal.pone.0330495 [GeneHero™ HEK293T/ACE2-TMPRSS2 Cell Line, Cat.No.:SL222]
Stella, J., et al. (2025). Development of an inhalable dry powder formulation for inhibition of SARS-CoV-2. Int J Pharm X DOI: 10.1016/j.ijpx.2025.100346 [GeneHero™ HEK293T/ACE2-TMPRSS2 Cell Line, Cat.No.:SL222]
Fu, Y., et al. (2025). Single cell and spatial alternative splicing analysis with Nanopore long read sequencing. Nat Commun DOI: 10.1038/s41467-025-60902-2 [GeneHero™ Jurkat cell line stably expressing CRISPR Cas9 nuclease, Cat. No. SL555]
Varela-Rouco, N., et al. (2025). Intraline genomic heterogeneity of the triple-negative breast cancer MDA-MB-231-luc-GFP cell line. Comput Struct Biotechnol J DOI: 10.1016/j.csbj.2025.06.033 [Luciferase/GFP Dual‐labeled MDA-MB-231 Cancer Cell Lines, Cat. No. SL018]
Du, S., et al. (2025). Clearance of protein aggregates during cell division. eLife DOI: 10.7554/eLife.96675 [Lenti-Pac™ 293Ta Packaging Cell Line, Cat. No. LT008]
Xiu, X., et al. (2025). Synergistic potential of bone marrow mesenchymal stem cells and miR181-a combinational therapy against multiple sclerosis. Stem Cell Res Ther DOI: 10.1186/s13287-025-04401-7 [293T human epithelial cell line; All-in-One™ miR First-Strand cDNA Synthesis Kit, Cat. No. QP113; All-in-One™ miRNA Universal Adaptor PCR Primer, Cat. No. QP029]
Kane, M.A., et al. (2025). Adhesion strength of tumor cells predicts metastatic disease in vivo. Cell Rep DOI: 10.1016/j.celrep.2025.115359 [Luciferase/GFP Dual‐labeled 4T-1 and CT26 Cancer Cell Lines, Cat. No. SL027]
Wang, B., et al. (2025). Structural Basis for Retron Co-option of Anti-phage ATPase-nuclease. bioRxiv DOI: 10.1101/2025.05.10.653283 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502]
Ciulla, D.A., et al. (2025). A general assay platform to study protein pharmacology using ligand-dependent structural dynamics. Nat Commun DOI: 10.1038/s41467-025-59658-6 [GeneHero™ HEK293 cell line stably expressing CRISPR SpCas9-HF nuclease, Cat. No. SL553]
Zhu, G., et al. (2025). PPM1B degradation mediated by TRIM25 ubiquitination modulates cell cycle and promotes gastric cancer growth. Sci Rep DOI: 10.1038/s41598-025-89519-7 [CRISPR-Cas9 genome editing system for PPM1B]
Lin, W-Y., et al. (2025). Multiple cAMP/PKA complexes at the STIM1 ER/PM junction specified by E-Syt1 and E-Syt2 reciprocally gates ANO1 (TMEM16A) via Ca2+. Nat Commun DOI: 10.1038/s41467-025-58682-w [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502; GeneHero™ sgRNA clones targeting Human AHCYL1, Cat. No. HCP291015-SG01-3]
Itson-Zoske, B., et al. (2025). Selective RNAi silencing of Schwann cell Piezo1 alleviates mechanical hypersensitization following peripheral nerve injury. Mol Ther Methods Clin Dev DOI: 10.1016/j.omtm.2025.101433 [GeneHero™ Neuro2a (N2A) cell line stably expressing CRISPR Cas9 nuclease]
González-Conde, M., et al. (2025). Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patients. J Transl Med DOI: 10.1186/s12967-025-06374-w [MCF7, Cat. No. CC172]
Kim, Y-M., et al. (2025). Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors. bioRxiv DOI: 10.1101/2025.03.21.644686 [GeneHero™ MDA-MB-231 cell line stably expressing CRISPR Cas9 nuclease, Cat. No. SL515]
Cheng, L., et al. (2025). PEBP1 amplifies mitochondrial dysfunction-induced integrated stress response. eLife DOI: 10.7554/eLife.102852 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502]
Yuan, Y., et al. (2025). A multistage drug delivery approach for colorectal primary tumors and lymph node metastases. Nat Commun DOI: 10.1038/s41467-025-56768-z [Luciferase/GFP Dual‐labeled COLO 205 Cancer Cell Line, Cat. No. SL005]

2024

Gupta, S., et al. (2024). Distinct properties and activation of hexameric and heptameric Pannexin 1 channel concatemers. J Gen Physiol DOI: 10.1085/jgp.202413676 [GeneHero™ HEK293T Cas9-expressing stable cell line, Cat. No. SL502]
Liu, X., et al. (2024). Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis. J Clin Invest DOI: 10.1172/JCI179527 [Luciferase/GFP Dual‐labeled 4T-1 and CT26 Cancer Cell Lines, Cat. No. SL020, SL021]
Stearns, K., et al. (2024). Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry. mBio DOI: 10.1128/mbio.02327-24 [GeneHero™ CRISPRa Stable Cell Lines HEK293 stably expressing dCas9-VP64 and MPH complex, Cat. No. SL302]
Hajj, S.E., et al. (2024). Bone Spheroid Development Under Flow Conditions with Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells in a 3D Porous Hydrogel Supplemented with Hydroxyapatite. Gels DOI: 10.3390/gels10100666 [Human bone marrow-derived mesenchymal stem cell stably expressing SV40 large T antigen and hTERT gene, Cat. No. SL428]
Moreno, P., et al. (2024). ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. bioRxiv. DOI: 10.1101/2024.03.12.584316 [OMICSLINK™ Human ADRA2A ORF expression clone and empty control, Cat. No. EX-Z5688-Lv103, EX-NEG-Lv103; Lenti-Pac™ HIV Expression Packaging Kit Cat. No. LT001]
Kocabiyik, O., et al. (2024). Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract. Sci Adv. DOI: 10.1126/sciadv.adn7786 [Firefly Luciferase + eGFP Lentifect™ SARS-CoV-2 D614G Spike-Pseudotyped Lentiviral Particles, ER retention signal removed, Cat. No. SP003-100; HEK293T cells stably expressing human ACE2 (NM_021804.2), Cat. No. SL221]
Guo, B., et al. (2024). Enhanced ApcMin/+ adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells. Neoplasia. DOI: 10.1016/j.neo.2024.101005 [Luciferase/GFP Dual‐labeled CT26 Cancer Cell Line, Cat. No. SL021]
Chen, K.M., et al. (2024). Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor. Front Immunol. DOI: 10.3389/fimmu.2024.1380065 [Luciferase/GFP Dual‐labeled MDA-MB-231 Cancer Cell Line, Cat. No. SL018]
Bacigalupa, Z.A., et al. (2024). HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma. J Clin Invest. DOI: 10.1172/JCI164249 [GeneHero™ 786-O Cas9-expressing stable cell line, Cat. No. SL577]
Elste, J., et al. (2024). Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion. Biomedicines. DOI: 10.3390/biomedicines12040821 [ACE2-expressing HEK293T stable cell line]
Silva, W.N., et al. (2024). Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression. Int J Nanomedicine. DOI: 10.2147/IJN.S452896 [Luciferase/GFP Dual‐labeled COLO 205 Cancer Cell Line, Cat. No.SL005]
Lutfiye Yildiz Ozer, et al. 2024.Development of a cancer metastasis-on-chip assay for high throughput drug screening. Front Oncol. DOI: 10.3389/fonc.2023.1269376 [stably expressed GFP of a pre-made eGFP-puro-CMV-lentiviral vector]
Asim G. Khan, et al. 2024.An experimental census of retrons for DNA production and genome editing. bioRxiv. DOI: 10.1101/2024.01.25.577267 [HEK293T Cell Line Stably Expressing CRISPR Cas9 Nuclease]

2023

Madeline Dahut, et al. 2023. Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis. J Immunother Cancer. DOI: 10.1136/jitc-2023-007386 [Short tandem repeat (STR) profiling]
Rachel Erickson, et al. 2023.SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition. Nat Commun. DOI: 10.1038/s41467-023-42140-6 [ACE2-expressing 293T cells, Cat.No. SL221; Luc-Pair™ Firefly Luciferase HS Assay Kit, Cat. No.LF007]
Min Luo, et al. 2023.A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block “eat-me” signal. Signal Transduct Target Ther. DOI: 10.1038/s41392-023-01545-x [Luciferase/GFP Dual‐labeled CT-26 Cancer Cell Line]
Elste, J., et al. (2023). Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry. Int J Mol Sci. doi: 10.3390/ijms241914792 [Lentifect™ SARS-CoV-2 D614G Spike-Pseudotyped Lentiviral Particles; Lenti-Pac™ HEK293T cell line]
Grimes, S.M., et al. (2023). Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer. NAR Cancer doi: 10.1093/narcan/zcad034 [GeneHero™ Jurkat Cas9-expressing stable cell line]
Shin, S.M., et al. (2023). Peripheral sensory neurons and non-neuronal cells express functional Piezo1 channels. Mol Pain doi: 10.1177/17448069231174315 [GeneHero™ Neuro2a Cas9-expressing stable cell line]
Kuroda, T., et al. (2023). Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. J Antimicrob Chemother doi: 10.1093/jac/dkad027 [ACE2 and TMPRSS2-expressing HEK293T cells]
Morimoto, M., et al. (2023). Bi-allelic ATG4D variants are associated with a neurodevelopmental disorder characterized by speech and motor impairment. NPJ Genom Med doi: 10.1038/s41525-022-00343-8 [GeneHero™ HeLa Cas9-expressing stable cell line]
Osaka, T., et al. (2023). Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2. Microorganisms doi: 10.3390/microorganisms11020471 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Chan, J.F-K., et al. (2023). Altered host protease determinants for SARS-CoV-2 Omicron. Sci Adv doi: 10.1126/sciadv.add3867 [ACE2-expressing HEK293T stable cell line]
Koch, J., et al. (2023). Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model. Viruses doi: 10.3390/v15020363 [GFP dual-labeled HT-29 cancer cell line]
Merluza, J., et al. (2023). Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiol Spectr doi: 10.1128/spectrum.03789-22 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Nakata, Y., et al. (2023). Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res doi: 10.1093/nar/gkac1238 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]

2022

hen, Y.A., et al. (2022). In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model. Gene Ther doi: 10.1038/s41434-022-00375-w [GeneHero™ HeLa Cas9-expressing stable cell line]
Travis, B.J., et al. (2022). Significance of chlorine‐dioxide‐based oral rinses in preventing SARS‐CoV‐2 cell entry. Oral Dis doi: 10.1111/odi.14319 [ACE2-expressing HEK293T stable cell line; Lentifect™ SARS-CoV-2 D614G Spike-Pseudotyped Lentiviral Particles]
Wang, X., et al. (2022). Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis. Neuron doi: 10.1016/j.neuron.2022.10.028 [Neuro2a stably expressing Cas9 from ROSA26 site]
Zhang, W.F., et al. (2022). SIRT1 inactivation switches reactive astrocytes to an antiinflammatory phenotype in CNS autoimmunity. J Clin Invest doi: 10.1172/JCI151803 [Neuro2a stably expressing Cas9 from ROSA26 site]
Moreau, F., et al. (2022). Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist. Nat Commun doi: 10.1038/s41467-022-34391-6 [GFP dual-labeled MCF7 cancer cell line]
Kim, Y.S., et al. (2022). Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction. Int J Mol Sci doi: 10.3390/ijms232012516 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Kim, Y.S., et al. (2022). Mulberrofuran G; a Mulberry Component; Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor. Nutrients doi: 10.3390/nu14194170 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Luo, W.S., et al. (2022). Pcdh11x controls target specification of mossy fiber sprouting. Front Neurosci doi: 10.3389/fnins.2022.888362 [Mouse cell line Neuro2a stably expressing Cas9 from ROSA26 site]
Han, S.T., et al. (2022). PUS7 deficiency in human patients causes profound neurodevelopmental phenotype by dysregulating protein translation. Molecular Genetics and Metabolism doi: 10.1016/j.ymgme.2022.01.103 [GeneHero™ HeLa Cas9-expressing stable cell line]
Hwang, J-Y., et al. (2022). Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals. Vaccines doi: 10.3390/vaccines10020332 [ACE2-expressing HEK293T stable cell line]
Fereydouni, M., et al. (2022). Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy. Frontiers in Oncology doi: 10.3389/fonc.2022.871390 [Luciferase + GFP labeled SK-BR-3 cell line]
Park, H., et al. (2022). TMED3 Complex Mediates ER Stress-Associated Secretionof CFTR, Pendrin, and SARS-CoV-2 Spike. Advanced Science doi: 10.1002/advs.202105320 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Sim, J-R., et al. (2022). Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition. Cell Reports doi: 10.1016/j.celrep.2022.111117 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Grodzki, M., et al. (2022). Genome-scale CRISPR screens identify host factors that promote human coronavirus infection. Genome Medicine doi: 10.1186/s13073-022-01013-1 [ACE2-expressing HEK293T stable cell line]
Ariumi, Y. (2022). Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection. Journal of Virology doi: 10.1128/jvi.00002 [ACE2-expressing HEK293T stable cell line]
Pivniouk, V., et al. (2022). The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression. Journal of Allergy and Clinical Immunology doi: 10.1016/j.jaci.2021.11.019 [ACE2-expressing HEK293T stable cell line]
Travis, B.J., et al. (2022). Significance of chlorine-dioxide-based oral rinses in preventing SARS-CoV-2 cell entry. Oral Diseases doi: 10.1111/odi.14319 [ACE2-expressing HEK293T stable cell line]
Zheng, W., et al. (2022). SIRT1 inactivation switches reactive astrocytes to an anti-inflammatory phenotype in CNS autoimmunity. The Journal of Clinical Investigation doi: 10.1172/JCI151803 [GeneHero™ Neuro2a Cas9-expressing stable cell line]

2021

Hashizume, M., et al. (2021). Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro. Viruses doi: 10.3390/v13010067 [ACE2-expressing HEK293T stable cell line]
Hana, S., et al. (2021) Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice. Gene Thereapy doi: 10.1038/s41434-021-00224-2 [GeneHero™ HeLa, Neuro2a Cas9-expressing stable cell lines]
Beitzel, B.F., et al. (2021). On‐Demand Patient‐Specific Phenotype‐to‐Genotype Ebola Virus Characterization. Viruses doi: 10.3390/ v13102010 [Custom stable cell line services]
Paidi, R.K., et al. (2021). Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. Journal of Neuroimmune Pharmacology doi: 10.1007/s11481-021-10028-1 [ACE2-expressing HEK293T stable cell line]
Song, Y., et al. (2021). A genome-wide CRISPR/Cas9 gene knockout screen identifies immunoglobulin superfamily DCC subclass member 4 as a key host factor that promotes influenza virus endocytosis. PLOS Pathogens doi: 10.1371/journal.ppat.1010141 [GeneHero™ A549 Cas9-expressing stable cell line]
Paidi, R.K., et al. (2021). Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. Journal of Immunology doi: 10.4049/jimmunol.2100144 [ACE2-expressing HEK293T stable cell line]

2020

Kasper, S.H., et al. (2020). Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Scientific Reports doi: 10.1038/s41598-020-62139-z [GFP labeled HT-29 cell line]
Reznikov, L.R., et al. (2020). Identification of antiviral antihistamines for COVID-19 repurposing. Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2020.11.095 [ACE2-expressing HEK293T stable cell line]
Pan, Y., et al. (2020). The nature of the modification at position 37 oftRNAPhecorrelates with acquired taxol resistance. Nucleic Acids Research doi: 10.1093/nar/gkaa1164 [TYW2 stable knockdown HeLa cell line]
Chaudhari, H.G., et al. (2020). Evaluation of Homology-Independent CRISPR-Cas9Off-Target Assessment Methods. The CRISPR Journal doi: 10.1089/crispr.2020.0053 [GeneHero™ HEK293 Cas9-expressing stable cell line]

2019

Howell, M.C., et al. (2019). Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis. FASEB Bio Advances doi: 10.1096/fba.2019-00081 [GFP labeled H1975 cell line]

2018

Sokhi, U.K., et al. (2018). Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models. Nature Communications doi: 10.1038/s41467-018-03081-7 [HEK293 Cas9-expressing stable cell line]
Zhao, D., et al. (2018). Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis. Molecular Cell doi: 10.1016/j.molcel.2018.01.017 [HeLa, HEK293 and A549 Cas9-expressing stable cell lines]

2017

Shen, J.P., et al. (2017). Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions. Nature Methods doi 10.1038/nmeth.4225 [HeLa, HEK293 and A549 Cas9-expressing stable cell lines]
Mitchell, M.J., et al. (2017). Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis. Nature Communications doi: 10.1038/ncomms14179 [dual-labelled luciferase and GFP+ COLO 205 colon cancer cell line]

Antibodies Publications

Lysosome Stains

LysoBeacon™ Blue, 1 mg/ml LysoBeacon™ Green, 1 mg/ml

Related Products

Stable Cell Lines Publications

Recent Posts

Recent Comments